Stockreport

Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154 [Yahoo! Finance]

Lipocine Inc.  (LPCN) 
Last lipocine inc. earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.lipocine.com
PDF SALT LAKE CITY Feb. 6, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leve [Read more]